Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
LANNETT COMP Add to My Watchlist (AMEX: LCI) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     LANNETT COMP 4.51 -0.04 (-0.88%) 2,300
9000 State Road
Philadelphia, PA 19136 US
(215) 333-9000
(215) 333-9004 fax
www.lannett.com
CEO Arthur P. Bedrosian
Auditor Grant Thornton LLP
Exchange Traded AM
ISIN Number US5160121019
CIK Number 57725
NAICS Code 325412
Business Summary
The Company develops, manufactures, packages, markets and distributes pharmaceutical products sold under generic chemical names.
Number of Employees 277
Share Fundamentals
Market Cap 112.06M
Shares Outstanding 24.85M
Float 10.25M
Short Interest 286.44K
Financial Strength
Revenue (TTM) $124,869,361
Earnings (TTM) $8,164,432
Quick Ratio 1.6:1
Current Ratio 2.2:1
Total Debt/Equity 0.1:1
Profitability
Gross Margin 42.3%
EBITDA Margin 14.7%
Profit Margin 10.6%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs